Information  X 
Enter a valid email address

Port Erin Biopharma (PEBI)

  Print      Mail a friend

Monday 18 June, 2012

Port Erin Biopharma

Director/PDMR Shareholding

RNS Number : 5331F
Port Erin Biopharma Investments Ltd
18 June 2012

Port Erin Biopharma Investments Limited


 ("Port Erin" or the "Company")


Director's Dealing



Port Erin, the AIM listed company focused on investing in the biotechnology and biopharmaceutical sectors, was informed that Galloway Limited purchased 500,000 Ordinary Shares at a price of 7 pence per share on 15 June 2012.


Galloway Limited is wholly owned by a trust in which Jim Mellon, Chairman of the Company, has a life tenancy. Denham Eke, a Director of the Company, is a director of Galloway Limited.


Following this transaction, the total Ordinary Shares in which Jim Mellon has a beneficial interest is 3,941,000, representing 11.8% of the issued ordinary share capital of the Company.






Port Erin Biopharma Investments Limited


Denham Eke

(+44) 1624 639396



Libertas Capital Corporate Finance Limited


Sandy Jamieson

(+44) 20 7569 9650



Rivington Street Corporate Finance Limited


John Levinson

(+44) 20 7562 3350


This information is provided by RNS
The company news service from the London Stock Exchange